Wockhardt arm inks COVID-19 vaccine supply deal with UK
The Indian Express Date: Aug 04, 2020 ENS Economic Bureau, drugmaker Wockhardt on Monday announced that it has entered into an agreement with the UK government to help supply COVID-19 vaccines to their population through a subsidiary facility in North Wales. The agreement is expected to help address a major supply challenge global vaccine makers have flagged during this pandemic — the need for enough vials to rapidly fill the finished vaccine solutions. In India, the firm is in talks with the government to provide its capacity to fill-finish (to fill vials) the vaccines at its facility in Aurangabad, which can cater around 600 million doses a year, as per Wockhardt founder chairman Dr Habil Khorakiwala. It is also in talks with various other vaccine manufacturers, currently in early stage human trials, for similar tie-ups. The agreement with the UK will make use of the 400-million vial capacity of Wockhardt’s subsidiary, Wrexham-based CP Pharmaceuticals, according t